Capsid-modified adeno-associated virus vectors as novel vaccine platform for cancer immunotherapy-Reference-Cited by-同舟云学术

Capsid-modified adeno-associated virus vectors as novel vaccine platform for cancer immunotherapy

Published:2023-06 Issue: Volume:29 Page:238-253
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Franke Ann-Christin,Hardet Romain,Prager Lisa,Bentler Martin,Demeules Mélanie,John-Neek Philipp,Jäschke Nico Martin,Ha Teng Cheong,Hacker Ulrich Thorsten,Adriouch Sahil,Büning Hildegard

Funder

Bundesministerium für Bildung und Forschung

Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg

Wilhelm Sander-Stiftung

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference58 articles.

1. Fundamental mechanisms of immune checkpoint blockade therapy;Wei;Cancer Discov.,2018

2. Engineered T cells: the promise and challenges of cancer immunotherapy;Fesnak;Nat. Rev. Cancer,2016

3. Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity;Yu;Mol. Cancer,2019

4. Cancer vaccines: toward the next breakthrough in cancer immunotherapy;Igarashi;J. Immunol. Res.,2020

5. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma;Sahin;Nature,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adeno-Associated Virus 5 Protein Particles Produced by E. coli Cell-Free Protein Synthesis;ACS Synthetic Biology;2024-08-23

2. Unlocking cancer vaccine potential: What are the key factors?;Human Vaccines & Immunotherapeutics;2024-04-02

3. Development and application of oncolytic viruses as the nemesis of tumor cells;Frontiers in Microbiology;2023-06-12